Newsletter
Every new paper in this field, in your inbox.
Trisectionectomies (TS) dramatically enhance overall and disease-free survival for patients with Bismuth-Corlette type II and III perihilar cholangiocarcinoma, outperforming standard hemihepatectomies (EH). In a study of 443 patients, TS improved overall survival to 52.4 months compared to 31 months for EH. Although TS resulted in…
A predictive model effectively identifies patients with non-functioning pancreatic neuroendocrine tumors (NF-PanNETs) at high risk for early recurrence (ER). Developed from a cohort of 496 patients, the model leverages preoperative clinical, pathological, and imaging variables, achieving an AUC of 0.91 in training and 0.84 in…
With primary liver cancer often diagnosed too late for surgery, systemic treatments are becoming vital. The review highlights advances in molecular targeted therapies and immunotherapies, including cutting-edge combinations that suppress disease progression, extend survival, and enhance quality of life for patients. Challenges in implementation remain,…
Despite advancements in surgical techniques, the incidence of postoperative pancreatic fistula (POPF) after pancreatoduodenectomy has risen, increasing from 13.3% in 2018 to 15.7% in 2023. Racial disparities impact outcomes, with Asian and other non-White patients facing higher risks. Conversely, preoperative chemotherapy appears to reduce POPF…
In 2021, Japan saw a significant drop in acute pancreatitis (AP) hospitalizations, declining to 61,080 cases from 78,450 in 2016, marking a 49 per 100,000 incidence rate. The mortality rate among severe cases improved to 5.3%, down from 6.1%. Treatment adherence improved; 61.2% of patients…
A novel prognostic score effectively stratifies hepatocellular carcinoma patients with microvascular invasion based on early recurrence factors. Evaluating 265 patients, it incorporates serum alpha-fetoprotein levels, hepatitis B e antigen status, and presence of satellite nodules. Higher scores correlate with significantly lower three-year recurrence-free and overall…
In a retrospective analysis involving 183 colorectal liver metastasis patients, 69% completed two-stage hepatectomy (tsh), achieving a median overall survival of 65.3 months compared to just 20.6 months for those who failed to complete it. The study identified key prognostic factors linking successful resections to…
Laparoscopic hepaticoduodenostomy (LHD) has emerged as a viable alternative to traditional Roux-en-Y hepaticojejunostomy for bilioenteric reconstruction. In a study involving 125 patients, LHD was successfully performed in 91.5% of cases with cholangiocarcinoma and 54.9% for benign biliary strictures. Key metrics included a mean operative time…
A study of 158 patients with obstructive jaundice in Rwanda revealed endoscopic retrograde cholangiopancreatography (ERCP) as the predominant intervention, achieving a technical success rate of 79.44%. Overall, procedural success reached 82.61%, with percutaneous transhepatic biliary drainage (PTBD) at 91.67% and surgical procedures at 100%. The…
Unresectable pancreatic cancer, with a bleak 5-year survival rate of 13.3%, has prompted a shift from traditional surgical interventions to innovative minimally invasive techniques. Researchers detail the evolution from open surgeries to procedures like endoscopic stent placement and percutaneous biliary drainage, improving patient quality of…
